Suxin Luo

Prof. Suxin Luo

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2022 in Inflammation
Verified
Journal Article
Closed access
PDF file
LHLongxiang Huang
Longxiang Huang
YLYuanjing Li
Yuanjing Li
ZCZhe Cheng
Zhe Cheng
ZLZi Lv
Zi Lv
SLSuxin Luo
Suxin Luo
YXYong Xia
Yong Xia

1 January 2023 in Theranostics
Verified
Journal Article
Open access
PDF file
YGYongzheng Guo
Yongzheng Guo
YYYuehua You
Yuehua You
FSFei-Fei Shang
Fei-Fei Shang
XWXiaowen Wang
Xiaowen Wang
BHBi Huang
Bi Huang
YXYong Xia
Yong Xia
Background: Sterile inflammation contributes to the pathogenesis of cardiac dysfunction caused by various conditions including pressure overload in hypertension. Mitochondrial DNA (mtDNA) released from damaged mitochondria has been implicated in cardiac inflammation. However, the upstream mechanisms governing mtDNA release and how mtDNA activates sterile inflammation in pressure-overloaded hearts remain largely unknown. Here, we investigated the role of inducible NO synthase (iNOS) on pressure overload-induced cytosolic accumulation of mtDNA and whether mtDNA activated inflammation through the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway.

5 March 2022 in Journal of Advanced Research
Verified
Journal Article
Open access
YGYongzheng Guo
Yongzheng Guo
JWJunjie Wen
Junjie Wen
AHAn He
An He
CQCan Qu
Can Qu
YPYuce Peng
Yuce Peng
XWXiao-Wen Wang
Xiao-Wen Wang
Despite the high morbidity and mortality of heart failure with preserved fraction (HFpEF), there are currently no effective therapies for this condition. Moreover, the pathophysiological basis of HFpEF remains poorly understood. The aim of the present study was to investigate the role of inducible nitric oxide synthase (iNOS) and its underlying mechanism in a high-fat diet and Nω-nitro-L-arginine methyl ester-induced HFpEF mouse model. The selective iNOS inhibitor L-NIL was used to examine the effects of short-term iNOS inhibition, whereas the long-term effects of iNOS deficiency were evaluated using iNOS-null mice. Cardiac and mitochondrial function, oxidative stress and Akt S-nitrosylation were then measured. The results demonstrated that both pharmacological inhibition and iNOS knockout mitigated mitochondrial dysfunction, oxidative stress and Akt S-nitrosylation, leading to an ameliorated HFpEF phenotype in mice. In vitro, iNOS directly induced Akt S-nitrosylation at cysteine 224 residues , leading to oxidative stress, while inhibiting insulin-mediated glucose uptake in myocytes. Altogether, the present findings suggested an important role for iNOS in the pathophysiological development of HFpEF, indicating that iNOS inhibition may represent a potential therapeutic strategy for HFpEF.

21 February 2022 in International Immunopharmacology
Verified
Journal Article
Closed access
HYHuilin Yu
Huilin Yu
QLQian Liu
Qian Liu
GCGuodong Chen
Guodong Chen
LHLongxiang Huang
Longxiang Huang
MINGHAO LUOMINGHAO LUO
MINGHAO LUO
SLSuxin Luo
Suxin Luo

26 October 2020 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
YYYuehua You
Yuehua You
YGYongzheng Guo
Yongzheng Guo
PJPing Jia
Ping Jia
BZBiaobiao Zhuang
Biaobiao Zhuang
YCYu Cheng
Yu Cheng
BHBi Huang
Bi Huang
Background: Ketogenic diet (KD) has been proposed to be an effective lifestyle intervention in metabolic syndrome. However, the effects of KD on cardiac remodeling have not been investigated. Our aim was to investigate the effects and the underling mechanisms of KD on cardiac remodeling in spontaneously hypertensive rats (SHRs). Methods: 10-week-old spontaneously hypertensive rats were subjected to normal diet or ketogenic diet for 4 weeks. Then, their blood pressure and cardiac remodeling were assessed. Cardiac fibroblasts were isolated from 1- to 3-day-old neonatal pups. The cells were then cultured with ketone body with or without TGF-β to investigate the mechanism in vitro. Results: 4 weeks of KD feeding aggravated interstitial fibrosis and cardiac remodeling in SHRs. More interestingly, ketogenic diet feeding increased the activity of mammalian target of rapamyoin (mTOR) complex 2 pathway in the heart of SHRs. In addition, β-hydroxybutyrate strengthened the progression of TGF-β-induced fibrosis in isolated cardiac fibroblasts. mTOR inhibition reversed this effect, indicating that ketone body contributes to cardiac fibroblasts via mTOR pathway. Conclusions: These data suggest that ketogenic diet may lead to adverse effects on the remodeling in the hypertensive heart, and they underscore the necessity to fully evaluate its reliability before clinical use.

1 October 2020 in Life Sciences
Verified
Journal Article
Closed access
YGYongzheng Guo
Yongzheng Guo
XWXiaowen Wang
Xiaowen Wang
PJPing Jia
Ping Jia
YYYuehua You
Yuehua You
YCYu Cheng
Yu Cheng
BHBi Huang
Bi Huang